NR1H4 and metabolic syndrome: After the administration of salidroside, tyrosol, and hydroxytyrosol to the respective groups, the levels of ALT, XOD, TNF-α, and FMO3 in metabolic syndrome mice markedly decreased, while the levels of TBA and FXR significantly increased (p < 0.05).